Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D6MEX0
|
|||
| Drug Name |
ALN-TMP
|
|||
| Drug Type |
Small interfering RNA
|
|||
| Indication | Beta thalassemia [ICD-11: 3A50.2; ICD-10: D56.1, D56.3] | Preclinical | [1] | |
| Company |
Alnylam Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | TMPRSS6 messenger RNA (TMPRSS6 mRNA) | Target Info | Inhibitor | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Targeting iron metabolism in drug discovery and delivery. Nat Rev Drug Discov. 2017 Jun;16(6):400-423. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.